Rumblings Over Russia’s COVID-19 Vaccine Approval
Reports Differ Over Immunization Program And Manufacturing
Amid concerns from vaccine experts over Russia’s approval of the first COVID-19 vaccine last week, questions remain over precisely when immunization will begin and the plans for Phase III trials.
You may also be interested in...
Two new projects have begun, one on standardizing the assessment of immune responses in individuals vaccinated in clinical trials, the other to improve understanding of potential immunity in patients who have been infected with SARS-CoV-2.
One effect of Brexit is that the UK’s National Institute for Biological Standards and Control will have additional responsibilities from next year in terms of the independent batch testing and release of products such as vaccines and medicines derived from human blood and plasma in Great Britain.